WithdrawnNot Applicable

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure

Stopped: No active recruitment

0Started 2019-10-01

Plain-language summary

Cardiac Heart Failure Questionnaire HF-Q) to assess the severity of the symptoms of Heart Failure. In this study, modified and translated, the "four-point" questionnaire by Severo and his associates - Heart Failure Questionnaire HF-Q, is used. The HF-Q Heart Failure Questionnaire consists of four closed questions: the first with four possible answers and the other three questions with the possibility of three simple-choice answers.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients with symptomatic Heart Failure NYHA≥2 * Patients who have fully understood the procedures of the study and have signed an informed consent form. Exclusion Criteria: * Patients with asymptomatic heart failure (NYHA = 1) * Patients with severe motor impairment / mobility impairment (neurological diseases, muscular diseases, severe anemia, previous mobility stroke, severe malignancy, end-stage COPD)

What they're measuring

Heart Failure Questionnaire (HF-Q)

Timeframe: 6 months

Major Adverse Cardiovascular Events (MACEs)

Timeframe: 6 months

Trial details

NCT IDNCT03947853

SponsorElpen Pharmaceutical Co. Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2020-01-31

View on ClinicalTrials.gov More Heart Failure trials